Chibaudel, B., Maindrault‐Gœbel, F., Bachet, J., Louvet, C., Khalil, A., Dupuis, O., . . . de Gramont, A. (2016). PEPCOL: A GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer. Cancer Med.
Styl cytowania ChicagoChibaudel, Benoist, et al. "PEPCOL: A GERCOR Randomized Phase II Study of Nanoliposomal Irinotecan PEP02 (MM‐398) or Irinotecan With Leucovorin/5‐fluorouracil As Second‐line Therapy in Metastatic Colorectal Cancer." Cancer Med 2016.
Styl cytowania MLAChibaudel, Benoist, et al. "PEPCOL: A GERCOR Randomized Phase II Study of Nanoliposomal Irinotecan PEP02 (MM‐398) or Irinotecan With Leucovorin/5‐fluorouracil As Second‐line Therapy in Metastatic Colorectal Cancer." Cancer Med 2016.